“We really are different than anything out there because, first off, we are in no way a diagnostic site. A lot of websites [prompt users] to put in symptoms and self-diagnose. That is a somewhat dangerous process,” explains Dr. Rocamboli. “The ability to diagnosis is truly is physician skill set. What treatments work, you can look that up in a book.”
But for those treatments that aren’t yet in the book, CureCrowd could one day be the go-to resource for physicians and patients. While the treatment data will remain anecdotal, using larger-scale anecdotal evidence to inform treatment decisions is better than having patients make decisions based on a single tale from a neighbor or coworker.
Take for example, the site’s data on depression treatments. Based on user-generated data, Celexa is the most effective drug to treat depression (see screenshot). Yet, running and yoga were rated as more effective overall than any drug, including Paxil, Prozac, Zoloft and Cymbalta.
“If one person says it, it’s one thing, says Dr. Rocamboli. “If a 1,000 people say it, then that’s another thing.”
Such a database could be especially helpful to patients with rare conditions. More patients are diagnosed with rare diseases than AIDS and cancer combined — and less than 400 FDA approved drugs are available to treat more than 7,000 rare diseases.
“We lend value to off-label and alternative use,” explains Dr. Rocamboli.
“Some very basic [naturally occurring] medicines like morphine and insulin would be not be developed by pharma today,” since pharmaceutical manufacturers tend to invest in synthetic drug development, he explains. “Today, those would be pushed off as alternative medicine.
“We circumvent the issue by aggregating data an giving leverage and justification to use that doesn’t have as much research supporting it,” he adds.
For patients with rare conditions, or for whom traditional treatments haven’t taken hold, a database like CureCrowd could be just what the doctor ordered.